IL6 and schizophrenia: Mendelian randomisation (MR) studies have reported associations of genetic variants regulating inflammatory biomarkers such as interleukin-6 (IL-6) with schizophrenia (Hartwig et al., 2017), suggesting that inflammation may be associated with schizophrenia beyond any effects of confounding.